相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen-induced bladder carcinogenesis
Koji Izumi et al.
MOLECULAR CARCINOGENESIS (2013)
MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer
Hiroshi Hirata et al.
CARCINOGENESIS (2012)
Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
H. Miyamoto et al.
CURRENT CANCER DRUG TARGETS (2012)
The Role of the Androgen Receptor in the Development and Progression of Bladder Cancer
Yi Li et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells
Yichun Zheng et al.
ENDOCRINE-RELATED CANCER (2011)
Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer
Ji-Tao Wu et al.
UROLOGY (2010)
Epstein-Barr Virus Latent Membrane Protein-1 Effects on Junctional Plakoglobin and Induction of a Cadherin Switch
Kathy H. Y. Shair et al.
CANCER RESEARCH (2009)
Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Kati K. Waltering et al.
CANCER RESEARCH (2009)
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
Stephen A. Boorjian et al.
ENDOCRINE-RELATED CANCER (2009)
Regulation of Myogenic Differentiation by Androgens: Cross Talk between Androgen Receptor/β-Catenin and Follistatin/Transforming Growth Factor-β Signaling Pathways
Rajan Singh et al.
ENDOCRINOLOGY (2009)
Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication
Efstathios Kastritis et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
Xiaochen Tian et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells
Yaxiong Tang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Tissue Culture Media Supplemented With 10% Fetal Calf Serum Contains a Castrate Level of Testosterone
J. P. Michiel Sedelaar et al.
PROSTATE (2009)
Crosstalk between the Androgen Receptor and beta-Catenin in Castrate-Resistant Prostate Cancer
Gang Wang et al.
CANCER RESEARCH (2008)
The first five years of the Wnt targetome
Annica Vlad et al.
CELLULAR SIGNALLING (2008)
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1
Aimee M Johnson et al.
BMC Urology (2008)
β-catenin signaling in biological control and cancer
Nancy Gavert et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Promotion of bladder cancer development and progression by androgen receptor signals
Hiroshi Miyamoto et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors
R Singh et al.
ENDOCRINOLOGY (2006)
Epidermal growth factor receptor:: A novel target of the Wnt/β-catenin pathway in liver
XP Tan et al.
GASTROENTEROLOGY (2005)
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer
R Stoehr et al.
LABORATORY INVESTIGATION (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
The adrenal androgen Androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor
A Mizokami et al.
CANCER RESEARCH (2004)
β-Catenin signaling in prostate cancer:: an early perspective
DR Chesire et al.
ENDOCRINE-RELATED CANCER (2003)
Functional localization and competition between the androgen receptor and T-cell factor for nuclear β-catenin:: a means for inhibition of the Tcf signaling axis
DJ Mulholland et al.
ONCOGENE (2003)
β-catenin mutations correlate with over expression of c-myc and cyclin D1 genes in bladder cancer
H Shiina et al.
JOURNAL OF UROLOGY (2002)
Liganded androgen receptor interaction with β-catenin -: Nuclear co-localization and modulation of transcriptional activity in neuronal cells
JE Pawlowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli
DJ Mulholland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Linking β-catenin to androgen-signaling pathway
FJ Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Aberrant expression of β-catenin and mutation of exon 3 of the β-catenin gene in renal and urothelial carcinomas
XD Zhu et al.
PATHOLOGY INTERNATIONAL (2000)
Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
T Brabletz et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
